ITI News Archive
Stanford Medicine News
Biomarker for flu susceptibility discovered
Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.
Cellular ‘death code’ discovered
Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.
Special diet helps bacteria engraft in gut
Gut bacteria able to digest seaweed can outcompete native bacteria in the large intestine of nori-fed mice, according to Stanford scientists. Favoring one species over others in the gut could help advance precision health.
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.
Older people’s immune cells diverge more
Stanford scientists, focusing on chemical adjuncts affixed to DNA-associated proteins, found that these markings become more diverse with age.
Altered immune cells attack brain tumor
In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.
Tough transplant cases? Hospital up to the task
Dane Conrads, now almost 4, was “desperately ill” when he received his liver transplant in 2014. Last year, he also benefited from one of the most complicated kidney transplants ever performed at Packard Children’s Hospital.
Conference on human immune monitoring
The two-day event will highlight the latest research by top scientists on technologies and analytic methods geared toward studying human immunology.
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.